Healthy volunteers needed to test safety of new drug DF5112
Knowledge-focused
Recruiting now
This early-stage study tests the safety of a new drug, DF5112, in 48 healthy adults aged 18 to 55. Participants receive either the drug or a placebo by injection and are monitored for about a week in a clinic, with follow-up visits over 29 days. The goal is to check for side effe…
Phase: PHASE1 • Sponsor: Dragonfly Therapeutics • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC